Research use only · EU-warehoused · COA on every batch · HPLC ≥99% · Shipment 2–5 days
Log in Register
Home/ Catalogue/ Combination Blends/ BPC-157 + TB-500
In stock
BPC-157 + TB-500

BPC-157 + TB-500

Lyophilised · ≥99% (HPLC) ·

Quantity Volume discounts auto-applied
Custom quantity
1

Supplied lyophilised. Reconstitution typically uses bacteriostatic water.

How to reconstitute BPC-157 + TB-500 — stock calculator
Independently third-party tested · COA on every batch · 48h EU dispatch
[01]

Overview

BPC-157 + TB-500 is a dual-peptide research blend combining BPC-157 (Body Protection Compound-157), a synthetic 15-amino-acid pentadecapeptide (sequence GEPPPGKPADDAGLV; CAS 137525-51-0; MW 1419.5 g/mol) derived from human gastric juice, with TB-500, a synthetic analogue of the actin-sequestering peptide Thymosin Beta-4 (CAS 77591-33-4; MW 4963 g/mol). Both components are supplied lyophilised at ≥99% purity by HPLC. For laboratory research use only; not for human or veterinary use.

This blend pairs two of the most extensively investigated peptides in regenerative and cytoprotective research, BPC-157 and TB-500, in a single co-formulated vial. The combination is studied because the two molecules act through largely distinct mechanisms — one rooted in gastric cytoprotection, the other in actin-binding cell motility — making them a frequent pairing in tissue-repair model systems.

Two repair peptides with separate origins. BPC-157 is a synthetic pentadecapeptide derived from a protective protein in gastric juice, characterised as a pleiotropic, stable agent in a large experimental literature (Sikiric et al., 2024). TB-500 is the synthetic, bioavailable fragment corresponding to the active region of thymosin β4, a naturally occurring actin-sequestering peptide expressed across many human tissues during development (Faa et al., 2024).

What the research explores. Each component has its own body of experimental work, and together they are studied across complementary repair themes:

  • Tendon, ligament & bone repair (BPC-157) — investigated for effects on tendon outgrowth and cell migration, ligament healing, and bone-defect models (Chang et al., 2011; Cerovecki et al., 2010; Sebecić et al., 1999).
  • Gastrointestinal cytoprotection (BPC-157) — studied for attenuation of experimentally induced gastric lesions (Petek et al., 1999).
  • Cell migration & organ-repair signalling (TB-500 / thymosin β4) — examined in wound-healing, renal, and broader regenerative contexts (He et al., 2026; Mason et al., 2023; Xing et al., 2021).

All of the activity described here comes from in-vitro and animal studies; these findings characterise biological behaviour in experimental models and do not demonstrate efficacy or safety in humans. Full citations are listed under the Scientific References tab.

Specification & quality. Each individually sealed vial contains 10 mg of BPC-157 and 10 mg of TB-500 as a white lyophilized powder at ≥99% purity by HPLC, soluble in water. Every batch is third-party tested, and a Certificate of Analysis (COA) is available. Store at −20 °C, protected from light and moisture; shelf life 24 months from the manufacture date.

This product is intended for laboratory research use only (RUO). It is not a drug, food, cosmetic, or dietary supplement, and is not for human or veterinary use, ingestion, or diagnostic application. Handling is restricted to qualified research professionals operating in an appropriately equipped laboratory.

Supplied for in-vitro laboratory research use only (RUO). Not a drug, food or supplement; not for human or veterinary use.

[04]

Quality & COA

Certificate of Analysis
Lot-specific COA with every order

Certificate of Analysis — lot-specific COA ships with every order and is available on request.

Each lot is tested by an independent third-party laboratory for identity (mass spectrometry) and purity (HPLC). The Certificate of Analysis for your specific batch ships with the order and is available on request — no house data, no exceptions.

HPLC purity
≥99% (HPLC)
Method
HPLC + MS
Endotoxin
Reported
[02]

Data Sheet

Purity≥99% (HPLC)
Physical formWhite lyophilized powder
QuantityBPC-157 10mg + TB-500 10mg
SolubilitySoluble in water
StorageStore at -20°C, protect from light
ReconstitutionReconstitute with bacteriostatic water or sterile saline.
Shelf life24 months from manufacture date
OriginEU · Slovakia
ClassificationResearch use only
[03]

Scientific References

01 Mateescu DM, Gavrilescu DM, Constantinescu FE, Oancea C, Ilie AC, Folescu R, et al. BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers. Pharmaceutics. 2026;18(5). PMID: 42198317. doi:10.3390/pharmaceutics18050625. PubMed 02 Yuan C, Demers A, Silva-Ortiz V, Hasoon JJ, Lee W, Dave K, et al. From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management. Int J Mol Sci. 2026;27(6). PMID: 41898733. doi:10.3390/ijms27062876. PubMed 03 McGuire FP, Martinez R, Lenz A, Skinner L, Cushman DM. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med. 2025;18(12):611-619. PMID: 40789979. doi:10.1007/s12178-025-09990-7. PubMed 04 Sikiric P, Boban Blagaic A, Strbe S, Beketic Oreskovic L, Oreskovic I, Sikiric S, et al. The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity. Pharmaceuticals (Basel). 2024;17(4). PMID: 38675421. doi:10.3390/ph17040461. PubMed 05 Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011;110(3):774-80. PMID: 21030672. doi:10.1152/japplphysiol.00945.2010. PubMed 06 Cerovecki T, Bojanic I, Brcic L, Radic B, Vukoja I, Seiwerth S, et al. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res. 2010;28(9):1155-61. PMID: 20225319. doi:10.1002/jor.21107. PubMed 07 Sebecić B, Nikolić V, Sikirić P, Seiwerth S, Sosa T, Patrlj L, et al. Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation. Bone. 1999;24(3):195-202. PMID: 10071911. doi:10.1016/s8756-3282(98)00180-x. PubMed 08 Petek M, Sikiric P, Anic T, Buljat G, Separovic J, Stancic-Rokotov D, et al. Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and mice. J Physiol Paris. 1999;93(6):501-4. PMID: 10672996. doi:10.1016/s0928-4257(99)00120-5. PubMed 09 Di H, Huang J, Zhang D, Ni F, Zheng R, Geng H. Thymosin beta 4: An emerging therapeutic candidate for kidney diseases. Peptides. 2026;195:171467. PMID: 41570941. doi:10.1016/j.peptides.2026.171467. PubMed 10 Faa G, Messana I, Coni P, Piras M, Pichiri G, Piludu M, et al. Thymosin β(4) and β(10) Expression in Human Organs during Development: A Review. Cells. 2024;13(13). PMID: 38994967. doi:10.3390/cells13131115. PubMed 11 Mason WJ, Vasilopoulou E. The Pathophysiological Role of Thymosin β4 in the Kidney Glomerulus. Int J Mol Sci. 2023;24(9). PMID: 37175390. doi:10.3390/ijms24097684. PubMed 12 Naeem A, Knoer G, Avantaggiati ML, Rodriguez O, Albanese C. Provocative non-canonical roles of p53 and AKT signaling: A role for Thymosin β4 in medulloblastoma. Int Immunopharmacol. 2023;116:109785. PMID: 36720193. doi:10.1016/j.intimp.2023.109785. PubMed 13 Xing Y, Ye Y, Zuo H, Li Y. Progress on the Function and Application of Thymosin β4. Front Endocrinol (Lausanne). 2021;12:767785. PMID: 34992578. doi:10.3389/fendo.2021.767785. PubMed 14 Wang Y, Carion TW, Ebrahim AS, Sosne G, Berger EA. Adjunctive Thymosin Beta-4 Treatment Influences PMN Effector Cell Function during Pseudomonas aeruginosa-Induced Corneal Infection. Cells. 2021;10(12). PMID: 34944086. doi:10.3390/cells10123579. PubMed 15 He S, Yuan M, Feng C, Zhang Y, Che J. Low-Temperature Fabrication of Thymosin β4-Loaded Soluble Microneedles to Promote Wound Healing by Specific Binding to Downregulated Immune Regulators Vsig4 and IL22rɑ2. Adv Healthc Mater. 2026;15(12):e04878. PMID: 41467542. doi:10.1002/adhm.202504878. PubMed

References are illustrative of the research literature surrounding this compound. All claims relate to in-vitro and animal models only.

[05]

FAQ

It is a single co-formulated, lyophilized vial pairing two extensively studied regenerative-research peptides: BPC-157 (10 mg), a gastric-derived 15-mer, and TB-500 (10 mg), a thymosin beta-4 fragment. It is supplied strictly as a Research Use Only reference material for in vitro and animal tissue-repair and cytoprotection studies.

The blend pairs them because BPC-157 and TB-500 act through different molecular pathways in tissue-repair models, so they are studied as complementary rather than overlapping reagents. Co-formulating both in one vial lets researchers investigate them together under identical conditions. For research use only, in vitro and animal models.

The blend co-formulates 10 mg BPC-157 and 10 mg TB-500 in one vial, reconstituted together, so the two are always studied at a fixed combined ratio. Buying them separately lets you vary each peptide independently. The amounts match the standalone 10 mg vials. Both formats are research use only.

The BPC-157 + TB-500 blend contains two repair peptides (10 mg each). GLOW adds GHK-Cu (50 mg), a copper-binding tripeptide studied in skin-regeneration and tissue-repair research, making it a three-peptide formulation. Choose the two-peptide blend for a simpler system, or GLOW to include the copper peptide. Research use only.

In peptide content, yes: the blend contains 10 mg BPC-157 and 10 mg TB-500, matching the standalone vial amounts. The difference is that they are co-formulated in a single vial and reconstituted together at a fixed ratio, rather than prepared independently. Research use only, in vitro and animal models.

Purity is verified per component. For blends, the >=99% HPLC specification applies to each peptide individually, confirmed by independent third-party testing before co-formulation, with a batch Certificate of Analysis. To request the COA covering both components for a specific lot, contact info@condorresearch.com.

Both peptides are water-soluble, so one diluent reconstitutes the blend in the lab. For example, adding 2 mL of bacteriostatic water to the 20 mg vial (10 mg + 10 mg) gives 5 mg/mL BPC-157 and 5 mg/mL TB-500; adjust volume for other target concentrations. For research preparation only, not human use.

Yes. Condor supplies the BPC-157 + TB-500 blend strictly as a Research Use Only (in vitro) reference material to professionals and institutions, not as a medicine or product for human or veterinary use. Buyers are responsible for confirming import legality in their country. Questions: info@condorresearch.com.

Store the sealed blend vial at -20C, protected from light; shelf life is 24 months from manufacture. Lyophilized peptide is stable for short room-temperature transit, so cold-pack shipping is generally not required. All preparation and handling is for in vitro and animal research only, never human or veterinary use.

[06]

Reviews

Leave a review
Earn 250 points for a verified review (account required).
4.8
42 verified reviews
5
79%
4
17%
3
5%
2
2%
1
0%
Apr 2026
Reference-grade consistency

Reconstitution was clean with no visible particulates. The lot-specific COA matched the assay we ran in-house — purity is exactly as stated.

Dr. M. Hartmann · Research lab · DE Verified purchase
Mar 2026
COA matched our own HPLC

We verify every incoming compound by HPLC; this batch came back within tolerance of the certificate. Dispatch from the EU warehouse was quick.

L. Fischer · University group · AT Verified purchase
Mar 2026
Impeccable packaging

Cold-chain handling was respected end to end. Vials arrived sealed, labelled and intact. Documentation is the most thorough I've seen from an EU supplier.

Dr. S. Novak · Private lab · CZ Verified purchase
Feb 2026
Reliable, well documented

Solubility and stability were as described. Knocked one star only because express shipping options are limited, but quality is not in question.

P. Andersson · Research institute · SE Verified purchase

Related compounds